Paul L Berns

Insider Reports History

Location
Watertown, MA
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Paul L. Berns
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul L Berns:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Title: Chief Executive Officer and Chairman of the Board, Director Common Stock 7,405,004 $12,528,526 $1.69 18 Feb 2025 Direct
Jazz Pharmaceuticals plc Director Ordinary Shares 8,290 $987,588 $119.13 05 Aug 2021 Direct
Neumora Therapeutics, Inc. Title: Chief Executive Officer and Chairman of the Board, Director Common Stock 133,097 $225,187 $1.69 18 Feb 2025 Indirect
Unity Biotechnology, Inc. Director Stock Option (Right to Buy) 10,000 $27,700 $2.77 21 Jun 2024 Direct
Metsera, Inc. Director Common Stock 0 $0 $52.33 13 Nov 2025 Direct
Metsera, Inc. Director Common Stock 0 $0 $52.33 13 Nov 2025 Indirect
Neumora Therapeutics, Inc. Title: Chief Executive Officer and Chairman of the Board, Director Stock Option (Right to Buy) 1,650,000 08 Jan 2026 Direct
Metsera, Inc. Director Restricted Stock Unit 4,031 13 Nov 2025 Direct
EQRx, Inc. Director Common Stock 0 $2.21 09 Nov 2023 Direct
EQRx, Inc. Director Earn-out Shares 0 09 Nov 2023 Direct
EQRx, Inc. Director Stock Option (Right to Buy) 0 09 Nov 2023 Direct
Metsera, Inc. Director Series A Convertible Preferred Stock 0 03 Feb 2025 Indirect
Metsera, Inc. Director Series B Convertible Preferred Stock 0 03 Feb 2025 Indirect
Metsera, Inc. Director Stock Option (right to buy) 0 13 Nov 2025 Direct

Insider Reports Filed by Paul L Berns

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMRA Neumora Therapeutics, Inc. 08 Jan 2026 1 $0 4 Title: Chief Executive Officer and Chairman of the Board, Director 09 Jan 2026, 16:17
MTSR Metsera, Inc. 13 Nov 2025 7 $0 4 Director 13 Nov 2025, 21:20
NMRA Neumora Therapeutics, Inc. 28 May 2025 8 $0 4 Title: Chief Executive Officer and Chairman of the Board, Director 30 May 2025, 18:30
MTSR Metsera, Inc. 20 May 2025 1 $0 4 Director 22 May 2025, 19:33
NMRA Neumora Therapeutics, Inc. 18 Feb 2025 1 -$23,468 4 Title: Chief Executive Officer and Chairman of the Board, Director 20 Feb 2025, 17:14
NMRA Neumora Therapeutics, Inc. 13 Feb 2025 7 $0 4 Title: Chief Executive Officer and Chairman of the Board, Director 18 Feb 2025, 16:30
MTSR Metsera, Inc. 03 Feb 2025 4 +$14,219,964 4 Director 03 Feb 2025, 19:04
MTSR Metsera, Inc. 30 Jan 2025 0 $0 3 Director, 10%+ Owner 30 Jan 2025, 21:37
NMRA Neumora Therapeutics, Inc. 27 Dec 2024 3 $0 4 Director 27 Dec 2024, 17:01
UBX Unity Biotechnology, Inc. 21 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:30
NMRA Neumora Therapeutics, Inc. 14 Feb 2024 2 $0 4 Director 16 Feb 2024, 16:17
/report/000089924323020307-berns-paul-l-2023-11-09 EQRx, Inc. 09 Nov 2023 3 $0 4 Director 09 Nov 2023, 16:18
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 Director 14 Sep 2023, 19:59
UBX Unity Biotechnology, Inc. 23 Jun 2023 1 $0 4 Director 26 Jun 2023, 17:12
/report/000110465923001121-berns-paul-l-2023-01-01 EQRx, Inc. 01 Jan 2023 1 $0 4 Director 04 Jan 2023, 20:57
/report/000110465922106015-berns-paul-l-2022-09-30 EQRx, Inc. 30 Sep 2022 1 $0 4 Director 04 Oct 2022, 20:07
UBX Unity Biotechnology, Inc. 24 Jun 2022 1 $0 4 Director 27 Jun 2022, 17:43
/report/000089924321049123-berns-paul-l-2021-12-17 EQRx, Inc. 17 Dec 2021 2 $0 4 Director 21 Dec 2021, 05:30
/report/000089924321049078-berns-paul-l-2021-12-17 EQRx, Inc. 17 Dec 2021 0 $0 3 Director 20 Dec 2021, 20:43
JAZZ Jazz Pharmaceuticals plc 05 Aug 2021 1 -$223,300 4 Director 09 Aug 2021, 18:37
UBX Unity Biotechnology, Inc. 24 Jun 2021 1 $0 4 Director 28 Jun 2021, 17:15